NovoCure (NVCR) Other financing activities (2018 - 2026)
NovoCure (NVCR) posted Other financing activities of $2.5 million for Q2 2026, up 529.49% sequentially from $390000.0 in Q1 2026, and up 878.09% YoY from $251000.0 in Q2 2025.
NovoCure (NVCR) Other financing activities (2018 - 2026) Analysis & Trends
NovoCure has reported Other financing activities for 9 years, with the latest figure at $2.5 million in Q2 2026.
- Quarterly Other financing activities rose 878.09% year-over-year to $2.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.5 million (down 45.25% YoY) and the FY2025 annual result came in at $6.1 million, up 183.53% from the prior year.
- Other financing activities grew to $2.5 million in Q2 2026 per NVCR's latest filing, from $390000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $5.2 million in Q1 2025 and troughed at $77000.0 in Q4 2025.
- A 5-year average of $1.8 million and a median of $1.0 million in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2024 and 2025: Other financing activities tumbled 95.91% in 2024, then surged 2363.38% in 2025.
- Over 5 years, Other financing activities stood at $952000.0 in 2022, then slumped by 60.4% to $377000.0 in 2023, then jumped by 91.51% to $722000.0 in 2024, then sank by 89.34% to $77000.0 in 2025, then surged by 3088.31% to $2.5 million in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $2.5 million, $390000.0, and $77000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | NovoCure | 2.07 Bn | 1.63 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46 Mn |
| Jun 30, 2026 | 2.46 Mn |
| Mar 31, 2026 | 390,000.00 |
| Mar 31, 2026 | 390,000.00 |
| Dec 31, 2025 | 77,000.00 |
| Dec 31, 2025 | 77,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Jun 30, 2025 | 251,000.00 |
| Jun 30, 2025 | 251,000.00 |
| Mar 31, 2025 | 5.25 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 722,000.00 |
| Dec 31, 2024 | 722,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 213,000.00 |
| Mar 31, 2024 | 213,000.00 |